Cytology and Genetics

, Volume 52, Issue 2, pp 127–131 | Cite as

Analysis of Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Gene K121Q Polymorphism Association with Some Risk Factors of Atherosclerosis in Patients with Acute Coronary Syndrome

  • A. V. Ataman
  • V. Yu. Harbuzova
  • O. A. Obukhova
  • Ye. I. Dubovyk
Article
  • 8 Downloads

Abstract

The present study was performed to investigate whether common single-nucleotide polymorphism K121Q (rs1044498) of the ENPP1 gene is associated with the known risk factors of atherosclerosis (overweight, dyslipoproteinemia, hypertension, diabetes, smoking, and hypercoagulability) in persons with acute coronary syndrome. Venous blood of 118 patients was genotyped for the polymorphism by PCR and restriction fragment length polymorphism method. In patients divided into two subgroups according to their genotype (KK and KQ + QQ), the statistically significant differences were revealed only for plasma LDL-cholesterol level and fibrinolytic activity. The carriers of minor allele (KQ + QQ) had lower LDL-cholesterol concentration and the time of fibrinolysis than the major allele homozygotes (KK). The division of patients into subgroups according to presence or absence of some risk factors for atherosclerosis showed no statistically significant differences between K121Q genotype distributions for any of the comparison.

Keywords

ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) acute coronary syndrome single nucleotide polymorphism risk factors 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Morgan, T.M., Krumholz, H.M., Lifton, R.P., and Spertus, J.A., Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study, J. Am. Med. Ass., 2007, vol. 297, no. 14, pp. 1551–1561.CrossRefGoogle Scholar
  2. 2.
    Morgan, T.M., Xiao, L., Lyons, P., Kassebaum, B., Krumholz, H.M., and Spertus, J.A., Investigation of 89 candidate gene variants for effects on all-cause mortality following acute coronary syndrome, BMC Med. Genet., 2008, vol. 9, no. 7, pp. 66–74.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Morgan, T.M., House, J.A., Cresci, S., Jones, P., Allayee, H., Hazen, S.L., Patel, Y., Patel, R.S., Eapen, D.J., Waddy, S.P., Quyyumi, A.A., Kleber, M.E., Marz, W., Winkelmann, B.R., Boehm, B.O., Krumholz, H.M., and Spertus, J.A., Investigation of 95 variants identified in a genome-wide study for association with mortality after acute coronary syndrome, BMC Med. Genet., 2011, vol. 12, no. 9, pp. 127–133.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Demer, L.L. and Tintut, Y., Inflammatory, metabolic, and genetic mechanisms of vascular calcification, Arterioscler. Thromb. Vasc. Biol., 2014, vol. 34, no. 4, pp. 715–723.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Lehto, S., Niskanen, L., Suhonen, M., Rönnemaa, T., and Laasko, I., Medial artery calcification: a neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus, Arterioscler. Thromb. Vasc. Biol., 1996, vol. 16, no. 8, pp. 978–983.CrossRefPubMedGoogle Scholar
  6. 6.
    Goldfine, I.D., Maddux, B.A., Youngren, J.F., Reaven, G., Accili, D., Trischitta, V., Vigneri, R., and Frittitta, L., The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase/phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities, Endocr. Rev., 2008, vol. 29, no. 1, pp. 62–75.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Shao, J.S., Cai, J., and Towler, D.A., Molecular mechanisms of vascular calcification: lessons learned from the aorta, Arterioscler. Thromb. Vasc. Biol., 2006, vol. 26, no. 7, pp. 1423–1430.CrossRefPubMedGoogle Scholar
  8. 8.
    Abedin, M., Tintut, Y., and Demer, L.L., Vascular calcification. mechanisms and clinical ramifications, Arterioscler. Thromb. Vasc. Biol., 2004, vol. 24, no. 7, pp. 1161–1170.CrossRefPubMedGoogle Scholar
  9. 9.
    Towler, D.A., Inorganic pyrophosphate. a paracrine regulator of vascular calcification and smooth muscle phenotype, Arterioscler. Thromb. Vasc. Biol., 2005, vol. 25, no. 4, pp. 651–654.CrossRefPubMedGoogle Scholar
  10. 10.
    Johnson, K., Polewski, M., van Etten, D., and Terkeltaub, R., Chondrogenesis mediated by PPi depletion promotes spontaneous aortic calcification in NPP1–/–mice, Arterioscler. Thromb. Vasc. Biol., 2005, vol. 25, no. 4, pp. 686–691.CrossRefPubMedGoogle Scholar
  11. 11.
    Pizzuti, A., Frittitta, L., Argiolas, A., Baratta, R., Goldfine, I.D., Bozzali, M., Ercolino, T., Scarlato, G., Iacoviello, L., Vigneri, R., Tassi, V., and Trischitta, V., A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance, Diabetes, 1999, vol. 48, no. 9, pp. 1881–1884.CrossRefPubMedGoogle Scholar
  12. 12.
    Costanzo, B.V., Trischitta, V., Di Paola, R., Spampinato, D., Pizzuti, A., Vigneri, R., and Frittitta, L., The Q allele variant (GLN121) of membrane glycoprotein PC-1 interacts with the insulin receptor and inhibits insulin signaling more effectively than the common K allele variant (LYS121), Diabetes, 2001, vol. 50, no. 4, pp. 831–836.CrossRefPubMedGoogle Scholar
  13. 13.
    Endler, G., Mannhalter, C., Sunder-Plassmann, H., Schillinger, I., Klimesch, A., Exner, M., Kapiotis, S., Meier, S., Kunz, F., Raiger, E., Huber, K., Wagner, O., and Sunder-Plassmann, R., The K121Q polymorphism in the plasma cell membrane glycoprotein 1 gene predisposes to early myocardial infarction, J. Mol. Med, 2002, vol. 80, no. 12, pp. 791–795.CrossRefPubMedGoogle Scholar
  14. 14.
    Bacci, S., Ludovico, O., Prudente, S., Zhang, Y.Y., Paola, R.D., Mangiacotti, D., Rauseo, A., Nolan, D., Duffy, J., Fini, G., Salvemini, L., Amico, C., Vigna, C., Pellegrini, F., Menzaghi, C., Doria, A., and Trischitta, V., The K121Q polymorphism of the ENPP1/PC-1 gene is associated with insulin resistance/atherogenic phenotypes, including earlier onset of type 2 diabetes and myocardial infarction, Diabetes, 2005, vol. 54, no. 10, pp. 3021–3025.CrossRefPubMedGoogle Scholar
  15. 15.
    Antman, E.M., Anbe, D.T., Armstrong, P.W., Aates, E.R., Green, L.A., Hand, M., Hochman, J.S., Krumholz, H.M., Kushner, F.G., Lamas, G.A., Mullany, C.J., Ornato, J.P., Pearle, D.L., Sloan, M.A., Smith, S.C., Jr., Alpert, J.S., Anderson, J.L., Faxon, D.P., Fuster, V., Gibbons, R.J., Gregoratos, G., Halperin, J.L., Hiratzka, L.F., Hunt, S.A., Jacobs, A.K., and Ornato, J.P., ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction, J. Am. Coll. Cardiol., 2004, vol. 44, no. 3, pp. 671–719.CrossRefPubMedGoogle Scholar
  16. 16.
    Thygesen, K., Alpert, J., White, H., Jaffe, A.S., Apple, F.S., Galvani, M., et al., Universal definition of myocardial infarction, Eur. Heart. J., 2007, vol. 28, no. 20, pp. 2525–2538.CrossRefPubMedGoogle Scholar
  17. 17.
    Terkeltaub, R.A., Inorganic pyrophosphate generation and disposition in pathophysiology, Am. J. Physiol. Cell Physiol., 2001, vol. 281, no. 1, pp. 1–11.CrossRefGoogle Scholar
  18. 18.
    Grupe, A., Alleman, J., Goldfine, I.D., Sadick, M., and Stewart, T.A., Inhibition of insulin receptor phosphorylation by PC-1 is not mediated by the hydrolysis of adenosine triphosphate or the generation of adenosine, J. Biol. Chem., 1995, vol. 270, no. 38, pp. 22085–22088.CrossRefPubMedGoogle Scholar
  19. 19.
    Chin, C.N., Dallas-Yang, Q., Liu, F., Ho, T., Ellsworth, K., Fischer, P., Natasha, T., Ireland, C., Lu, P., Li, C., Wang, I.M., Strohl, W., Berger, J.P., An, Z., Zhang, B.B., and Jiang, G., Evidence that inhibition of insulin receptor signaling activity by PC-1/ENPP1 is dependent on its enzyme activity, Eur. J. Pharmacol., 2009, vol. 606, nos. 1–3, pp. 17–24.CrossRefPubMedGoogle Scholar
  20. 20.
    Maddux, B.A., Chang, Y.N., Accili, D., Mcguinness, O.P., Youngren, J.F., and Goldfine, I.D., Overexpression of the insulin receptor inhibitor PC-1/ENPP1 induces insulin resistance and hyperglycemia, Am. J. Physiol. Endocrinol. Metab., 2006, vol. 290, no. 4, pp. 746–749.CrossRefGoogle Scholar

Copyright information

© Allerton Press, Inc. 2018

Authors and Affiliations

  • A. V. Ataman
    • 1
  • V. Yu. Harbuzova
    • 1
  • O. A. Obukhova
    • 1
  • Ye. I. Dubovyk
    • 1
  1. 1.Sumy State UniversitySumyUkraine

Personalised recommendations